The invention relates to novel compounds corresponding to the general formula(I) below:(see above formula)and also to their use in pharmaceutical compositions for preventing ortreating a conditionin humans and other mammals characterized by undesired thrombosis oralternatively foreffect on blood coagulation or blood plasma coagulation in vitro by inhibitionof factor Xa.